Myriad Genetics, Inc. (MYGN)
5.66
-0.02
(-0.35%)
USD |
NASDAQ |
Nov 13, 16:00
5.645
-0.02
(-0.27%)
After-Hours: 19:59
Myriad Genetics Enterprise Value : 643.96M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 643.96M |
| November 12, 2026 | 645.88M |
| November 11, 2026 | 649.70M |
| November 10, 2026 | 644.92M |
| November 09, 2026 | 651.62M |
| November 06, 2026 | 668.84M |
| November 05, 2026 | 704.25M |
| November 04, 2026 | 678.41M |
| November 03, 2026 | 680.33M |
| November 02, 2026 | 662.14M |
| October 30, 2026 | 710.00M |
| October 29, 2026 | 740.62M |
| October 28, 2026 | 736.79M |
| October 27, 2026 | 704.25M |
| October 26, 2026 | 678.41M |
| October 23, 2026 | 659.27M |
| October 22, 2026 | 653.53M |
| October 21, 2026 | 635.35M |
| October 20, 2026 | 632.48M |
| October 19, 2026 | 505.20M |
| October 16, 2026 | 483.19M |
| October 15, 2026 | 518.60M |
| October 14, 2026 | 499.46M |
| October 13, 2026 | 492.76M |
| October 12, 2026 | 504.24M |
| Date | Value |
|---|---|
| October 09, 2026 | 514.77M |
| October 08, 2026 | 504.24M |
| October 07, 2026 | 511.90M |
| October 06, 2026 | 511.90M |
| October 05, 2026 | 540.61M |
| October 02, 2026 | 536.78M |
| October 01, 2026 | 490.84M |
| September 30, 2026 | 514.77M |
| September 29, 2026 | 499.69M |
| September 28, 2026 | 500.64M |
| September 25, 2026 | 493.95M |
| September 24, 2026 | 491.08M |
| September 23, 2026 | 478.66M |
| September 22, 2026 | 479.61M |
| September 21, 2026 | 478.66M |
| September 18, 2026 | 467.18M |
| September 17, 2026 | 491.08M |
| September 16, 2026 | 464.32M |
| September 15, 2026 | 466.23M |
| September 14, 2026 | 457.62M |
| September 11, 2026 | 422.25M |
| September 10, 2026 | 416.52M |
| September 09, 2026 | 400.26M |
| September 08, 2026 | 399.31M |
| September 04, 2026 | 400.26M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Labcorp Holdings, Inc. | 36.61B |
| Natera, Inc. | 45.20B |
| Sera Prognostics, Inc. | 39.06M |
| BioRestorative Therapies, Inc. | -1.659M |
| CareDx, Inc. | 3.864B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -43.90M |
| Revenue (Quarterly) | 202.70M |
| Total Expenses (Quarterly) | 246.60M |
| EPS Diluted (Quarterly) | -0.4587 |
| Gross Profit Margin (Quarterly) | 64.04% |
| Profit Margin (Quarterly) | -21.66% |
| Earnings Yield | -24.08% |
| Normalized Earnings Yield | -23.01 |